BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12784562)

  • 1. [Requirements for the use of ELISA systems in eradication programs].
    Bogner KH
    Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):259-62. PubMed ID: 12784562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnostic markers in the prevention of bovine herpesvirus type 1: possibilities and limitations].
    Beer M; König P; Schielke G; Trapp S
    Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):183-91. PubMed ID: 12784550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Eradication of BHV-1 in cattle herds in Saxony-Anhalts using a vaccine lacking a marker--report of an experience].
    Gehrmann B; Tyrpe A; Körber R
    Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):203-7. PubMed ID: 12784553
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [BHV-1 eradication program in Bavaria: a marker-independent strategy].
    Truyen U; Isa G; Gerbermann H; Bogner KH; Banzhaf K; Köstler M; Pauels FJ; Czerny CP; Wittkowski G
    Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):197-202. PubMed ID: 12784552
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Conventional and marked BHV-1 vaccines in Germany: a brief review].
    Trapp S; König P; Beer M
    Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):208-15. PubMed ID: 12784554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy of intranasally and parenterally administered infectious bovine rhinotracheitis vaccines.
    McKercher DG; Crenshaw GL
    J Am Vet Med Assoc; 1971 Dec; 159(11):1362-9. PubMed ID: 4341681
    [No Abstract]   [Full Text] [Related]  

  • 7. A blocking ELISA with improved sensitivity for the detection of passively acquired maternal antibodies to BHV-1.
    Cho HJ; Entz SC; Green GT; Jordan LT
    Can Vet J; 2002 Jan; 43(1):43-5. PubMed ID: 11802669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of levamisole and bovine interferon alpha 1 on bovine immune responses and susceptibility to bovine herpesvirus-1.
    Babiuk LA; Ohmann HB
    Prog Clin Biol Res; 1984; 161():433-42. PubMed ID: 6091152
    [No Abstract]   [Full Text] [Related]  

  • 9. A combined bovine herpesvirus 1 gB-gD DNA vaccine induces immune response in mice.
    Caselli E; Boni M; Di Luca D; Salvatori D; Vita A; Cassai E
    Comp Immunol Microbiol Infect Dis; 2005 Mar; 28(2):155-66. PubMed ID: 15582691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of serum antibodies to bovine herpesvirus-1 and bovine viral diarrhea virus in beef cattle in Uruguay.
    Guarino H; Núñez A; Repiso MV; Gil A; Dargatz DA
    Prev Vet Med; 2008 Jun; 85(1-2):34-40. PubMed ID: 18280598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccination trials against bovine herpesvirus-1.
    Castrucci G; Ferrari M; Salvatori D; Sardonini S; Frigeri F; Petrini S; Lo Dico M; Marchini C; Rotola A; Amici A; Provinciali M; Tosini A; Angelini R; Cassai E
    Vet Res Commun; 2005 Aug; 29 Suppl 2():229-31. PubMed ID: 16244962
    [No Abstract]   [Full Text] [Related]  

  • 12. Detection of bovine herpesvirus-1 infection in breeding bull semen by virus isolation and polymerase chain reaction.
    Deka D; Ramneek ; Maiti NK; Oberoi MS
    Rev Sci Tech; 2005 Dec; 24(3):1085-94. PubMed ID: 16642777
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial protection induced by a BHV-1 recombinant vaccine against challenge with BHV-5.
    Spilki FR; Silva AD; Hübner S; Esteves PA; Franco AC; Driemeier D; Roehe PM
    Ann N Y Acad Sci; 2004 Oct; 1026():247-50. PubMed ID: 15604501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiologically non-feasible singleton reactors at the final stage of BoHV1 eradication: serological evidence of BoHV2 cross-reactivity.
    Böttcher J; Boje J; Janowetz B; Alex M; König P; Hagg M; Götz F; Renner K; Otterbein C; Mages J; Meier N; Wittkowski G
    Vet Microbiol; 2012 Oct; 159(3-4):282-90. PubMed ID: 22578637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Abortifacient vaccines and bovine herpesvirus-1.
    O'Toole D; Van Campen H
    J Am Vet Med Assoc; 2010 Aug; 237(3):259-60. PubMed ID: 20712064
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparative study of serological tests for use in the bovine herpesvirus 1 eradication programme in The Netherlands.
    de Wit JJ; Hage JJ; Brinkhof J; Westenbrink F
    Vet Microbiol; 1998 Mar; 61(3):153-63. PubMed ID: 9631527
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative studies with three different bovine blood sample BHV-1 ELISA tests: indirect ELISA and bG-blocking-ELISA].
    Isa G; Schelp C; Truyen U
    Berl Munch Tierarztl Wochenschr; 2003; 116(5-6):192-6. PubMed ID: 12784551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunogenicity of bovine rhinotracheitis--virus diarrhea vaccine in cattle inoculated simultaneously with concentrated homologous antiserum.
    Lambert G; Boylan CG; Rea C
    Vet Med Small Anim Clin; 1967 Nov; 62(11):1087-9. PubMed ID: 4294704
    [No Abstract]   [Full Text] [Related]  

  • 19. Evaluation of the efficacy of a modified-live combination vaccine against abortion caused by virulent bovine herpesvirus type 1 in a one-year duration-of-immunity study.
    Ficken MD; Ellsworth MA; Tucker CM
    Vet Ther; 2006; 7(3):275-82. PubMed ID: 17039450
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization against bovine herpesvirus-1 infection. Preliminary tests in calves with a DNA vaccine.
    Castrucci G; Ferrari M; Marchini C; Salvatori D; Provinciali M; Tosini A; Petrini S; Sardonini Q; Lo Dico M; Frigeri F; Amici A
    Comp Immunol Microbiol Infect Dis; 2004 May; 27(3):171-9. PubMed ID: 15001312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.